VetCell's Stem Cell Technique to Undergo Human Trials

VetCell Bioscience's pioneering stem cell technique, which is used to return injured horses to top levels of performance, will be tested in human medicine. The trials will be conducted by VetCell's parent company MedCell Bioscience Ltd under the guidance of David Glover, MD, former medical director of Cambridge Antibody Technologies, Professor Nicola Maffulli, MD, MS, PhD, FRCS(Orth), one of

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.

Sign In
Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More

Free Newsletters

Sign up for the latest in:

From our partners